Urology
Volume 75, Issue 3 , Pages 500-501 , March 2010

Reply

References 

  1. Drummond M, Sculpher MJ, Torrance GM. Methods for the Economic Evaluation of Health Care Programmes. Oxford, UK: Oxford University Press; 2005;
  2. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996;
  3. IOM. Quality of life and technology assessment (Monograph of the Council for Healthcare Technology). ed. M. F. and F.-T. J. Washington DC: National Academy Press; 1989;
  4. Reeves P, Irwin D, Kelleher C, et al. The current and future burden and cost of overactive bladder in five European countries. Eur Urol. 2006;50(5):1050–1057
  5. Subak L, Van Den Eeden S, Thom D, et al. Urinary incontinence in women: direct costs of routine care. Am J Obstet Gynecol. 2007;197(6):596;e1-e9
  6. Wu EQ, Birnbaum H, Marynchenko M, et al. Employees with overactive bladder: work loss burden. J Occup Environ Med. 2005;47(5):439–446

PII: S0090-4295(09)02513-8

doi: 10.1016/j.urology.2009.09.002

Urology
Volume 75, Issue 3 , Pages 500-501 , March 2010

Article Tools